Skip to content
Riskpilot
← Back to search
Sign in
Get full access
PHARMADAN A/S
A/S
Active
CVR 26524938
Englandsvej 350-356, 2770
Kastrup
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2002 · 24 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
PHARMADAN A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-1M
-2M
-3M
-3M
-3M
2021
-3M
2022
-5M
2023
-6M
2024
-6M
2025
EBITDA
DKK millions
0M
-2M
-4M
-6M
-8M
-3M
2021
-3M
0%
2022
-5M
-67%
2023
-6M
-20%
2024
-6M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-2.844
-3.128
-4.923
-5.841
-6.383
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-2.844
-3.128
-4.923
-5.841
-6.383
Depreciation & amort.
-314
-312
-292
-233
-86
EBIT
-3.158
-3.440
-5.215
-6.074
-6.469
Net financials
-61
-89
-190
-482
-660
Profit before tax
-3.220
-3.529
-5.405
-6.556
-7.129
Tax
-708
-776
-1.237
-1.442
-1.702
Net profit
-2.511
-2.753
-4.168
-5.114
-5.427
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
3.113
2.683
4.518
6.822
2.217
Equity
-1.494
-4.247
-8.415
-13.528
-18.955
Long-term debt
0
0
0
0
0
Short-term debt
4.608
6.930
12.933
20.350
21.172
Total debt
4.608
6.930
12.933
20.350
21.172
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-638265400.0%
This company
2021
2025
Equity ratio
-854.9%
This company
38.2%
Market median
-2338% vs market
2021
2025
Return on equity
-542664100.0%
This company
18.4%
Market median
-2949261513% vs market
2021
2025
Net profit margin (of gross profit)
-542664100.0%
This company
2021
2025
Asset turnover (of gross profit)
-2.88×
This company
2021
2025
Debt / equity
1.12×
This company
0.62×
Market median
-81% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
View
PDF
More on PHARMADAN A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
